Overview

This trial is active, not recruiting.

Condition parkinson's disease
Sponsor Muhammad Ali Parkinson Research Center
Collaborator Barrow Neurological Foundation
Start date November 2003
End date December 2015
Trial size 20000 participants
Trial identifier NCT00217321, 03BN117

Summary

The purpose of the Parkinson's disease Registry is to develop a national and international database of persons with Parkinson's disease (PD). The Registry will be used to facilitate the development of new therapies and healthcare services to improve the quality of life for people with PD. It will also be a means for investigators in the field of PD to quickly identify and notify subjects about other research studies for which they are eligible.

Objectives include:

- Assess current treatment approaches and develop best-practice guidelines

- Track the functional abilities, access to healthcare and cost of illness of people with PD over time

- Drive the development of innovative research projects

- Accelerate the process of informing patients of research projects for which they may be eligible

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model ecologic or community
Time perspective prospective

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Clinical diagnosis of Parkinson's disease Exclusion Criteria: - No clinical diagnosis of Parkinson's disease

Additional Information

Official title Parkinson's Disease Registry
Principal investigator Abraham Lieberman, MD
Description What do you need to know? - Any individual diagnosed with PD is eligible to enroll. - Participation in the registry is voluntary, confidential and free of charge. - Eligible participants will be notified about opportunities to participate in clinical trials, though they are under no obligation to enter. - Participants will need to complete an updated questionnaire every six months. - Participants may also be asked to complete additional surveys for PD research projects. - Any data provided will be used in scientific publications in summary form only. - Participant names will not be released to anyone outside the Parkinson's disease Registry management team without written authorization, nor will names be sold for advertising or fund-raising purposes.
Trial information was received from ClinicalTrials.gov and was last updated in July 2010.
Information provided to ClinicalTrials.gov by Muhammad Ali Parkinson Research Center.